Cantonnel Tablet 35 mg (Risedronate Sodium)

Adult dose

1. Adults : Administer 35 mg of risedronate sodium orally once weekly. 2. Older adults : No dosage adjustment is necessary in older adults (over 60 years of age), because the bioavailability and pharmacodynamics of this medication are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This medication is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. ○ Food interferes with the absorption of this medication. To ensure adequate absorption, take it at least 30 minutes before breakfast, or at least 2 hours before or after consuming food or beverages at any time of day. To help this medication reach the stomach easily and reduce the possibility of esophageal irritation, take it while upright with an adequate amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medication because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take the medication on the scheduled day, take it the next morning when remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

The safety and efficacy of this medication in children under 18 years of age have not been established.

This medication may irritate the gastrointestinal mucosa, so individuals with diseases of the esophagus, stomach, or duodenum should exercise particular caution. It is important to take this medicine with a sufficient amount of water, and not to lie down for a certain period after taking it. If there are problems with the esophagus or symptoms of swallowing difficulty occur, use should be discontinued immediately and a physician consulted. Individuals with specific diseases, pregnant women, or those with severely impaired kidney function should not take this medicine. Additionally, those with allergies to lactose or colorants contained in this medication should also be cautious. It’s important to ensure adequate intake of calcium and vitamin D while taking this medicine and to take supplements as directed by a physician if necessary. This medication has minimal drug interactions; however, it may interfere with the absorption of other drugs such as calcium or antacids, so a time gap should be maintained between doses. Rarely, serious side effects such as unusual bone fractures or jaw necrosis may occur with long-term use, so any unusual symptoms require immediate consultation with a physician. Pregnant or nursing women are advised to avoid taking this medication, and should consult a doctor if necessary. The safety in children has not been established, hence it should not be administered to anyone under 18 years of age. Caution is necessary for overdose as symptoms like hypocalcemia may occur, and appropriate measures should be taken under a physician's guidance. This medication should be stored out of reach of children and kept in its original container.

• esophagitis
• esophageal ulcer
• esophageal erosion
• esophageal obstruction
• esophageal perforation
• hemorrhage
• gastric ulcer
• duodenal ulcer
• dyspepsia
• diarrhea

This medication should be stored in an airtight container, preferably between 1℃ and 30℃. Proper storage will maintain the drug's effectiveness and prevent deterioration.

Appearance

Pale orange oval film-coated tablet

Package unit

4 tablets/PTP